Prosecutors raid Korean Exchange in Samsung Bio probe

Mar 15, 2019

Samsung Biologics is again in the spotlight over its 2016 initial public offering as prosecutors raided the office of the Korea Exchange.

Prosecutors suspect the stock market operator eased regulations to allow the CMO to list on the country's top-tier stock market. During the raid, investigators collected documents and hard drives, looking for information related to the IPO.

Last year, financial regulators accused Samsung Biologics of committing a $4 billion accounting fraud in 2015, inflating its value tied to its Biogen-partnered affiliate Samsung Bioepis. 

Read the Asian Review coverage

Want to get content like this in your inbox?  Subscribe to our eNewsletter here!

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments